Medical Xpress: Transcatheter Tricuspid Valve Replacement Aids Tricuspid Regurgitation
For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields substantial improvement in symptoms, function, and quality of life, according to a study published online Oct. 30 in the Journal of the American College of Cardiology.
Suzanne V. Arnold, MD, from Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, and colleagues performed an in-depth analysis of the health status of patients enrolled in the TRISCEND II pivotal trial. Patients with symptomatic and severe or greater TR were randomly assigned to TTVR with the EVOQUE tricuspid valve replacement system plus OMT or OMT alone (259 and 133 patients, respectively).
Read the full Medical Xpress article: Transcatheter Tricuspid Valve Replacement Aids Tricuspid Regurgitation
Recent News
News
Media Coverage: Doctor Weighs In on Patrick Mahomes’ ACL Recovery After Chiefs Confirm Injury
News
KMBC: Santa Surprises Saint Luke’s NICU Families With Special Holiday Visit
News
Media Coverage: Grandfather Grateful To Be Alive After Grandson’s Quick Thinking Saved His Life
Patient Stories
Roadside Heroics Lead One Grandfather to Lifesaving Care at Saint Luke’s Mid America Heart Institute
Patient Stories
A Team Effort Brings Patient Back to Life at Saint Luke’s Mid America Heart Institute
News